Creative Financial Designs Inc. ADV Sells 626 Shares of Doximity, Inc. (NASDAQ:DOCS)

Creative Financial Designs Inc. ADV reduced its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 14.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 3,580 shares of the company’s stock after selling 626 shares during the quarter. Creative Financial Designs Inc. ADV’s holdings in Doximity were worth $191,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Global Retirement Partners LLC lifted its position in Doximity by 468.1% in the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock worth $29,000 after buying an additional 440 shares during the last quarter. UMB Bank n.a. lifted its position in Doximity by 69.1% in the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after buying an additional 235 shares during the last quarter. Larson Financial Group LLC lifted its position in Doximity by 49.4% in the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock worth $40,000 after buying an additional 250 shares during the last quarter. Morse Asset Management Inc bought a new stake in Doximity in the third quarter worth $46,000. Finally, IFP Advisors Inc lifted its position in Doximity by 344.1% in the fourth quarter. IFP Advisors Inc now owns 1,328 shares of the company’s stock worth $71,000 after buying an additional 1,029 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors.

Doximity Stock Performance

Shares of NASDAQ DOCS opened at $62.68 on Thursday. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $85.21. The company has a market cap of $11.70 billion, a PE ratio of 62.68, a P/E/G ratio of 4.10 and a beta of 1.34. The business has a 50-day simple moving average of $64.04 and a two-hundred day simple moving average of $53.14.

Insider Buying and Selling

In related news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares of the company’s stock, valued at $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 37.40% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Leerink Partners upgraded Doximity from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $60.00 to $90.00 in a research report on Friday, February 7th. Needham & Company LLC increased their target price on Doximity from $65.00 to $82.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. JPMorgan Chase & Co. increased their target price on Doximity from $30.00 to $48.00 and gave the stock a “neutral” rating in a research note on Thursday, November 21st. Leerink Partnrs upgraded Doximity from a “hold” rating to a “strong-buy” rating in a research note on Friday, February 7th. Finally, Raymond James reiterated an “outperform” rating and issued a $83.00 target price (up previously from $65.00) on shares of Doximity in a research note on Friday, February 7th. Eleven research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, Doximity has an average rating of “Moderate Buy” and an average price target of $64.22.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.